Drug Shortage Report for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

Last updated on 2024-09-20

Report ID 237153
Drug Identification Number 02193221
Brand name THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Common or Proper name THIAMINE HYDROCHLORIDE INJECTION 100MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) THIAMINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 10mL vial / fiole
ATC code A11DA
ATC description VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-09-13
Actual start date
Estimated end date 2024-09-19
Actual end date 2024-09-17
Shortage status Resolved
Updated date 2024-09-20
Company comments There was a delay in the product's manufacturing. Product still available at CPDN.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-09-20 French Compare
v5 2024-09-20 English Compare
v4 2024-09-14 English Compare
v3 2024-09-10 French Compare
v2 2024-09-10 English Compare
v1 2024-09-10 English Compare

Showing 1 to 6 of 6